Home > Compound List > Product Information
Acarbose_Molecular_structure_CAS_56180-94-0)
Click picture or here to close

Acarbose

Catalog No. DB00284 Name DrugBank
CAS Number 56180-94-0 Website http://www.ualberta.ca/
M. F. C25H43NO18 Telephone (780) 492-3111
M. W. 645.60482 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 169

SYNONYMS

IUPAC name
(2R,3R,4R,5S,6R)-5-{[(2R,3R,4R,5S,6R)-5-{[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-{[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4-triol
IUPAC Traditional name
acarbose
Brand Name
Precose
Prandase
Glucobay

DATABASE IDS

PubChem CID 441184
CAS Number 56180-94-0
PubChem SID 46508248

PROPERTIES

Hydrophobicity(logP) -6.8

DETAILS

Description (English)
Item Information
Drug Groups approved; investigational
Description An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load. It is given orally to non-insulin dependent diabetes mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. (From Martindale The Extra Pharmacopoeia, 31st ed)
Indication For treatment and management of diabetes type II (used in combination therapy as a second or third line agent)
Pharmacology Used to reduce blood gluose in patients with type 2 diabetes. Acarbose is a complex oligosaccharide that delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals. Acarbose binds to and inhibits alpha amylase and alpha-gluocside hydrolases. In diabetic patients, this enzyme inhibition results in a delayed glucose absorption and a lowering of postprandial hyperglycemia.
Affected Organisms
Humans and other mammals
Absorption Extremely low bioavailability.
Half Life 2 hours
Elimination The fraction of acarbose that is absorbed as intact drug is almost completely excreted by the kidneys.
References
Clissold SP, Edwards C: Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 1988 Mar;35(3):214-43. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

REFERENCES

  • Clissold SP, Edwards C: Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 1988 Mar;35(3):214-43. Pubmed